{"id":1438,"date":"2024-12-03T10:29:51","date_gmt":"2024-12-03T10:29:51","guid":{"rendered":"https:\/\/ncdconnect.org\/?page_id=1438"},"modified":"2025-07-16T12:34:14","modified_gmt":"2025-07-16T12:34:14","slug":"ncd-market-pathway","status":"publish","type":"page","link":"https:\/\/ncdconnect.org\/en\/ncd-market-pathway\/","title":{"rendered":"NCD Market Pathway"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#001A70&#8243; width=&#8221;100%&#8221; max_width=&#8221;none&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;18px&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_font=&#8221;|300|||||||&#8221; custom_margin=&#8221;1px||||false|false&#8221; custom_padding=&#8221;|14.5%||22%|false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; header_2_line_height=&#8221;1.4em&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\"><\/span><\/strong><\/h1>\n<h1><strong><span style=\"color: #ffffff;\">NCD Market Pathway<\/span><\/strong><\/h1>\n<h2><span style=\"color: #ffffff;\">Your Partner in Expanding Access to Noncommunicable Diseases Treatments &amp; Medical Devices<\/span><\/h2>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/2023\/12\/How-it-works-page_picture.jpg&#8221; title_text=&#8221;NCD Market Pathway&#8221; show_bottom_space=&#8221;off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||-13px|||&#8221; custom_padding=&#8221;12px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>NCDconnect is <strong>your advisor in navigating the complexities of market entry for noncommunicable diseases<\/strong> (NCD) treatments and medical devices in low- and middle-income countries (LMICs). Leveraging <a href=\"https:\/\/www.idafoundation.org\/\" target=\"_blank\" rel=\"noopener\">IDA Foundation<\/a>\u2019s 50+ years of experience, NCDconnect supports you in <strong>overcoming regulatory and operational challenges<\/strong>, allowing you to <strong>reach new patient populations through a coordinated, efficient approach<\/strong>.<\/p>\n<p>With a <strong>programmatic and customised approach<\/strong>, NCDconnect is dedicated to building long-term partnerships that <strong>bring essential treatments and medical devices to markets with significant gaps<\/strong>.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/ncdconnect.org\/en\/new-book-a-demo\/&#8221; button_text=&#8221;Get Started&#8221; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_border_radius=&#8221;10px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_2_font_size=&#8221;22px&#8221; header_3_text_color=&#8221;#001A70&#8243; custom_padding=&#8221;0px|0px||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243; header_3_font=&#8221;|700|||||||&#8221;]<\/p>\n<h3><span style=\"color: #001a70;\">Advantages of Partnering with NCDconnect<\/span><\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-29px|auto||auto||&#8221; custom_padding=&#8221;||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; text_font_size=&#8221;16px&#8221; header_3_font=&#8221;|600|||||||&#8221; header_3_font_size=&#8221;20px&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#4F9AB0&#8243; header_4_font_size=&#8221;20px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><span style=\"color: #4f9ab0;\">Simplified Strategic Market Entry &amp; Expansion<\/span><\/h4>\n<ul>\n<li><strong>\u00a0<\/strong><strong>Access to New Markets:<\/strong> Unlock early access to growing markets without the burden of generating demand independently.<\/li>\n<li><strong>Regulatory Navigation Made Easy:<\/strong> Reduce risks and regulatory complexities with expert guidance, ensuring smooth, low-hurdle market entry.<\/li>\n<li><strong>Valuable Market Intelligence:<\/strong> Make informed decisions based on local insights, backed by our strategic ecosystem approach.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; text_font_size=&#8221;16px&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#4F9AB0&#8243; header_3_font_size=&#8221;20px&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#4F9AB0&#8243; header_4_font_size=&#8221;20px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Simplified End-to-end Supply Chain Management<\/h4>\n<ul>\n<li><strong>\u00a0<\/strong><strong>Operational Efficiency:<\/strong> Rely on our supply chain expertise in order fulfilment, distribution, and stock-keeping, allowing you to focus on your core business.<\/li>\n<li><strong>Lower Transactional Costs:<\/strong> Reduce administrative and operational expenses with simplified, long-term contracts, that eliminate the need for ad-hoc sourcing.<\/li>\n<li><strong>Safe Transactions:<\/strong> Access a network of vetted buyers for secure transactions and guaranteed payments.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|-43px|auto||&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/Teal-Blue-dots-vintage-1.png&#8221; title_text=&#8221;Teal Blue dots vintage&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;5%&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; text_font_size=&#8221;16px&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#4F9AB0&#8243; header_3_font_size=&#8221;20px&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#4F9AB0&#8243; header_4_font_size=&#8221;20px&#8221; custom_margin=&#8221;||48px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4 style=\"text-align: center;\">Simplified Pathways to Impactful Results<\/h4>\n<p style=\"text-align: center;\">Through our combined efforts in market entry facilitation and supply chain management, benefit from consistent, aggregated demand through consolidated procurement processes that translate into steady, long-term orders.<\/p>\n<p style=\"text-align: center;\">Together, we can develop sustainable solutions that not only streamline your operations but also enhance patient access to essential treatments and medical devices.<\/p>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#001A70&#8243; divider_position=&#8221;center&#8221; divider_weight=&#8221;1px&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;16px|auto||auto||&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;16px&#8221; header_3_text_color=&#8221;#001A70&#8243; custom_margin=&#8221;2px|||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><strong>Creating Impact, Together<\/strong><\/h3>\n<p>Of the 413 NCD medicines launched between 2013 and 2022, <strong>only 55% reached patients in LMICs<\/strong>. At NCDconnect, we believe every patient deserves access to effective therapies, regardless of where they live. That\u2019s why we work side-by-side with innovative manufacturers to make access to best-in-class NCD medicines a reality.<\/p>\n<p>The results speak for themselves; here\u2019s what meaningful collaboration can look like:<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/18.png&#8221; alt=&#8221;Blurry picture of the people who survived cancer on a wall in an oncology service&#8221; title_text=&#8221;NCDconnect &#038; ACT for children Thumbnail&#8221; url=&#8221;https:\/\/ncdconnect.org\/en\/ncdconnect-act-for-children-paediatric-cancer-gap-news\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#4F9AB0&#8243; link_option_url=&#8221;https:\/\/ncdconnect.org\/en\/ncdconnect-act-for-children-paediatric-cancer-gap-news\/&#8221; link_option_url_new_window=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><strong>ACT for Children | Servier \u2013 Paediatric Cancer Initiative<\/strong><\/h4>\n<p><strong>Challenge:<\/strong> For many hospitals in LMICs, access to affordable, quality-assured medicines like peg-asparaginase for acute lymphoblastic leukaemia remains out of reach.<\/p>\n<p><strong>Our Contribution:<\/strong> We coordinated the end-to-end supply chain, from aligning with Servier, forwarders, and local hospitals to managing import documentation and ensuring temperature-controlled air shipments with data-logger monitoring.<\/p>\n<p><strong>Results:<\/strong> $2.8M in oncology medicines delivered to five hospitals across Asia and Central America, supporting more than 1,000 children.<\/p>\n<p><a href=\"https:\/\/ncdconnect.org\/en\/ncdconnect-act-for-children-paediatric-cancer-gap-news\/\" target=\"_blank\" rel=\"noopener\"><strong>Read the full story here.<\/strong><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/7-1.png&#8221; alt=&#8221;An health practicioner is reassuring a patient&#8221; title_text=&#8221;Nilotinib access in LMICs thumbnail&#8221; url=&#8221;https:\/\/ncdconnect.org\/en\/expanding-access-to-nilotinib-in-low-income-countries-news\/&#8221; url_new_window=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#4F9AB0&#8243; link_option_url=&#8221;https:\/\/ncdconnect.org\/en\/expanding-access-to-nilotinib-in-low-income-countries-news\/&#8221; link_option_url_new_window=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><strong>Novartis &#8211; Hetero | Access to Nilotinib in Low-Income Countries<\/strong><\/h4>\n<p><strong>Challenge: <\/strong>Access to affordable, quality-assured nilotinib for chronic myeloid leukaemia remains limited in many LICs due to high prices and complex market entry barriers.<\/p>\n<p><strong>Our Contribution: <\/strong>Following Novartis\u2019 voluntary licence agreement for nilotinib, we collaborated with the ATOM Coalition, the Medicines Patent Pool (MPP), the generic manufacturer Hetero and with local authorities in five countries, to fast-track supply and enable platform-based procurement.<\/p>\n<p><strong>Results:<\/strong> Nilotinib is now available via NCDconnect, with generic versions priced up to 10 times lower than the branded product, significantly easing the financial burden on patients and health systems.<\/p>\n<p><a href=\"https:\/\/ncdconnect.org\/en\/expanding-access-to-nilotinib-in-low-income-countries-news\/\" target=\"_blank\" rel=\"noopener\"><strong>Read the full story here.<\/strong><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>These collaborations show what\u2019s possible when we connect expertise across the ecosystem: <strong>seamless supply chain<\/strong>, <strong>effective market entry<\/strong>, and <strong>real, measurable impact<\/strong>.\u00a0<em>More partnership success stories coming soon.<\/em><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#4F9AB0&#8243; custom_padding=&#8221;29px||11px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_font_size=&#8221;26px&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\">These trusted suppliers have already chosen to partner up:<\/span><\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;none&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/SMALL-print_ready-5in-300dpi-ABBOTT-Logo-signature-horizontal_2c_bk_pan_c.jpg&#8221; alt=&#8221;Abbott Logo&#8221; title_text=&#8221;Logo&#8221; show_bottom_space=&#8221;off&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;||||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/Logo_RGB-1.png&#8221; alt=&#8221;Logo of Fresenius Kabi, global health care company&#8221; title_text=&#8221;Logo_RGB (1)&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|50px||50px|false|true&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/2023\/12\/Hetero-Logo2.jpg&#8221; title_text=&#8221;Hetero&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.25.2&#8243; _module_preset=&#8221;default&#8221; module_alignment=&#8221;center&#8221; height=&#8221;137px&#8221; max_height=&#8221;1000px&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10%||10%||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/HUIYU-LOGO.png&#8221; alt=&#8221;Psychotropics India Limited&#8221; title_text=&#8221;Huiyu logo&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;75%&#8221; custom_padding=&#8221;||60px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_5,1_5,1_5,1_5,1_5&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;none&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/i-SENS_small.jpg&#8221; alt=&#8221;i SENS small&#8221; title_text=&#8221;i SENS small&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;56%&#8221; custom_padding=&#8221;40px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/Logo-JEWIM.png&#8221; alt=&#8221;Logo of Jewim Pharmaceutical&#8221; title_text=&#8221;Logo JEWIM&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;50px|30px||30px|false|true&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/Remedica-Logo-portrait.png&#8221; alt=&#8221;Logo of Remedica, global generics manufacturer&#8221; title_text=&#8221;Remedica-Logo-portrait&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|50px|40px|50px|false|true&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/2023\/11\/220110_SANOFI_LOGO_CMYK-scaled.jpg&#8221; title_text=&#8221;Sanofi&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.25.2&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;10%||10%||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_5&#8243; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;margin: auto;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/ncdconnect.org\/wp-content\/uploads\/SERVIER_LOGO_COLOR.png&#8221; alt=&#8221;Logo of Servier, an independent pharmaceutical company, leader in oncology&#8221; title_text=&#8221;SERVIER logo Colour&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; height=&#8221;100px&#8221; custom_padding=&#8221;10%||10%||true|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#4F9AB0&#8243; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|300|||||||&#8221; text_font_size=&#8221;18px&#8221; text_line_height=&#8221;1.4em&#8221; header_3_font_size=&#8221;26px&#8221; custom_margin=&#8221;||14px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\">Ready to make a difference?<\/span><\/h3>\n<p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Contact us today to explore how NCDconnect can support your market entry and supply chain needs.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/ncdconnect.org\/en\/contact-us-2\/&#8221; button_text=&#8221;Get in touch&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_border_width=&#8221;0px&#8221; button_border_radius=&#8221;9px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NCD Market Pathway Your Partner in Expanding Access to Noncommunicable Diseases Treatments &amp; Medical DevicesNCDconnect is your advisor in navigating the complexities of market entry for noncommunicable diseases (NCD) treatments and medical devices in low- and middle-income countries (LMICs). Leveraging IDA Foundation\u2019s 50+ years of experience, NCDconnect supports you in overcoming regulatory and operational challenges, [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-1438","page","type-page","status-publish","hentry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false,"et-pb-post-main-image":false,"et-pb-post-main-image-fullwidth":false,"et-pb-portfolio-image":false,"et-pb-portfolio-module-image":false,"et-pb-portfolio-image-single":false,"et-pb-gallery-module-image-portrait":false,"et-pb-post-main-image-fullwidth-large":false,"et-pb-image--responsive--desktop":false,"et-pb-image--responsive--tablet":false,"et-pb-image--responsive--phone":false},"uagb_author_info":{"display_name":"Esme Fowler-Mason","author_link":"https:\/\/ncdconnect.org\/en\/author\/esmefm\/"},"uagb_comment_info":0,"uagb_excerpt":"NCD Market Pathway Your Partner in Expanding Access to Noncommunicable Diseases Treatments &amp; Medical DevicesNCDconnect is your advisor in navigating the complexities of market entry for noncommunicable diseases (NCD) treatments and medical devices in low- and middle-income countries (LMICs). Leveraging IDA Foundation\u2019s 50+ years of experience, NCDconnect supports you in overcoming regulatory and operational challenges,&hellip;","_links":{"self":[{"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/pages\/1438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/comments?post=1438"}],"version-history":[{"count":51,"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/pages\/1438\/revisions"}],"predecessor-version":[{"id":2467,"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/pages\/1438\/revisions\/2467"}],"wp:attachment":[{"href":"https:\/\/ncdconnect.org\/en\/wp-json\/wp\/v2\/media?parent=1438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}